Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs;...
This bill could help families understand the costs and pricing shifts for prescription drugs.
Do you support it?
Want to know if it passes?
We'll email you when HB 5941 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HB 5941.
You're tracking HB 5941
We'll email you the moment it moves.
HB 5941 — Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.
Last action — bill electronically reproduced 05/12/2026
No card. One bill, free forever — alerts when it moves.
-
1Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has been introduced in the House. Introduced May 13, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
In plain language
The bill requires drug manufacturers to report cost information for certain prescription drugs.
This legislation mandates that drug manufacturers submit detailed cost reports to the state when increasing drug prices above specific thresholds. It aims to enhance transparency in prescription drug pricing.
What this means for you
- Families: This bill could help families understand the costs and pricing shifts for prescription drugs.
Summary
Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.
Bill Text
- Introduced House Introduced Bill Current pdf
Action History
-
bill electronically reproduced 05/12/2026
Sponsors
- Karl Bohnak · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 146 not signed on
Sponsors (1)
- Karl Bohnak Republican
Co-sponsors (0)
None.
Not signed on (146)
146 members have not signed on to this bill.
Show all 146 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 5941 do?
- Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.
- Who sponsors HB 5941?
- HB 5941 is sponsored by Karl Bohnak (Republican).
- What is the current status of HB 5941?
- This bill has been introduced in the House. Introduced May 13, 2026. It must pass committee before a floor vote.
- Where can I track HB 5941?
- Track HB 5941 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 5941
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 5941
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →